The Allogeneic Future with Poseida's Kristin Yarema, Ph.D.
Business Of Biotech
Exploring the Future of Allogeneic Therapies in Oncology and Autoimmunity
This chapter explores the advantages of allogeneic therapies over autologous therapies, particularly in CAR T-cell treatments. It highlights manufacturing challenges and the promise of cell therapy for autoimmune diseases, emphasizing the need for scalable production to enhance patient access.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
